COMMUNIQUÉS West-GlobeNewswire

Gritstone Oncology Announces Changes to its Board of Directors, Including the Appointment of Biotech Veteran Dr. Elaine V. Jones
12/09/2019
EMERYVILLE, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer [...]
Salarius Pharmaceuticals Supports Childhood Cancer Awareness Month
12/09/2019
Salarius’ lead program, Seclidemstat, is in a Phase 1 clinical trial for Ewing sarcoma, a rare and devastating pediatric bone and soft-tissue cancer; Early cohort data expected in 2020 HOUSTON, Sept. 12, 2019 (GLOBE [...]
Immunomedics to Host Investor Event and Webcast on September 28, 2019 During ESMO Congress
12/09/2019
MORRIS PLAINS, N.J., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
Alimera Announces Expansion of Agreement with Distribution Partner Horus Pharma to Include Marketing ILUVIEN® in Benelux Countries
12/09/2019
Following successful launch of ILUVIEN in France, Horus will bring the product to patients in Belgium, the Netherlands, and Luxembourg ATLANTA, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“ [...]
MRI Interventions to Present at Sidoti Conference
12/09/2019
IRVINE, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (NYSE American: MRIC) today announced that Chief Executive Officer Joe Burnett will present at the at the Sidoti Fall Investor Conference on [...]
AMAG Sends Letter to Shareholders
12/09/2019
Urges Shareholders Take No Action On Caligan Consent Solicitation WALTHAM, Mass., Sept. 12, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) (“AMAG” or the “Company”) today issued the following letter, [...]
CareDx launches AlloSeq® cfDNA at ESOT 2019
12/09/2019
CareDx will establish access to dd-cfDNA surveillance solutions for transplant patients worldwide BRISBANE, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company [...]
Bhang Inks Deal with Cannavative Group to Manufacture and Distribute Award-Winning THC-Infused Chocolates in Nevada
12/09/2019
Bhang’s award-winning chocolates will be available in nearly 65 outlets in Nevada MIAMI, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Bhang Inc. (“Bhang” or the “Company”) (CSE: BHNG) (OTCQX: BHNGF) , a global cannabis house of [...]
Ovid Therapeutics Announces First Patient Randomized in Pivotal Phase 3 NEPTUNE Trial of OV101 for the Treatment of Angelman Syndrome
12/09/2019
OV101 May Become the First Medicine for Individuals with Angelman Syndrome; Topline Results Expected in Mid-2020 NEW YORK, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical [...]
BioSig Technologies Signs a New Licensing Agreement with Mayo Clinic
12/09/2019
New Agreement to Support Development of Advanced Features of PURE EP™ System Westport, CT, Sept. 12, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing a [...]
TG Therapeutics Presents Data for Ublituximab at the 35th Annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
12/09/2019
NEW YORK, Sept. 12, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today presented the first look at the ULTIMATE I & II Phase 3 trial design and demographic data and updated Phase 2 extension trial [...]
Ogilvy Health’s Michael Zilligen Named One of the Most 100 Inspiring Leaders in Healthcare Marketing by PharmaVOICE
12/09/2019
PARSIPPANY, N.J., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Ogilvy Health, part of Ogilvy ( www.ogilvy.com ), today announced Michael Zilligen, Market Access Practice Lead, has been named to the “ PharmaVOICE 100 Most [...]
AgraFlora Organics fournit une mise à jour en lien avec la construction et le processus d’obtention de licence concernant son usine de fabrication de produits comestibles certifiée GMP d’une superficie de 51 500 pieds carrés
12/09/2019
VANCOUVER, Colombie-Britannique, 12 sept. 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF), une société internationale de [...]
REPEAT – AgraFlora Organics Provides Licensing Guidance and Construction Update Regarding 51,500 Sq./Ft. GMP Edibles Manufacturing Facility
12/09/2019
VANCOUVER, British Columbia, Sept. 12, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA ) ( Frankfurt: PU31 ) ( OTCPK: AGFAF ), a growth oriented and [...]
YSS Corp. Announces Opening of 12th Retail Cannabis Store and Provides Operational Update
12/09/2019
CALGARY, Alberta, Sept. 12, 2019 (GLOBE NEWSWIRE) -- YSS Corp.™ (the “ Company ” or “ YSS ”) (TSXV: YSS) (WKN: A2PMAX) is pleased to announce that, with the opening of both the YSS NW Landing store in Edmonton last week [...]
Tonix Pharmaceuticals to Speak at the 2019 Annual National Association of Veterans’ Research and Education Foundations (NAVREF) Conference
12/09/2019
NEW YORK, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), today announced that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will [...]
10x Genomics Announces Pricing of Initial Public Offering
12/09/2019
PLEASANTON, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (“10x Genomics”) today announced the pricing of its initial public offering of its Class A common stock at a price of $39.00 per share, before [...]
Wright Medical Group N.V. Highlights Recent Innovations and Clinical Data at the American Orthopaedic Foot & Ankle Society (AOFAS) 2019 Annual Meeting
12/09/2019
Company to Showcase CARTIVA ® Synthetic Cartilage Implant, PROstep ™ Minimally Invasive Surgery System, Total Ankle Continuum of Care and AUGMENT ® Injectable Bone Graft Company Completes Enrollment in UK-based Post- [...]
New Research Demonstrate Biogen’s Continued Commitment to Improve Care of Patients with Multiple Sclerosis Across Treatment Spectrum
12/09/2019
Data highlight benefits of TYSABRI ® (natalizumab) treatment in early multiple sclerosis for achieving NEDA (no evidence of disease activity) and improving disability and cognition An analysis of data from the TYSABRI [...]

Pages